ArticleJournal of the American Chemical Society2026
Genki Fukasawa, Yuma Matsuoka, Duy Phuoc Tran, Haruka Nishigaki, Keisuke Fukunaga, Takayoshi Watanabe, Tomohiro Doura, Naohiro Terasaka, Ako Kagawa, Takeshi Murata and 3 more
Abstract read
In one paragraphArticle in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Genki FukasawaSchool of Life Science and Technology, Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.
Yuma MatsuokaDepartment of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Aichi 464 8603, Japan.
Duy Phuoc TranSchool of Life Science and Technology, Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.ORCID 0000-0001-8212-3706 Haruka NishigakiSchool of Life Science and Technology, Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.
Keisuke FukunagaEarth-Life Science Institute (ELSI), Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.ORCID 0000-0002-4259-4359 Takayoshi WatanabeEarth-Life Science Institute (ELSI), Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.
Tomohiro DouraDepartment of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Aichi 464 8603, Japan.
Naohiro TerasakaEarth-Life Science Institute (ELSI), Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.ORCID 0000-0002-4988-6899 Ako KagawaEarth-Life Science Institute (ELSI), Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.
Takeshi MurataDepartment of Chemistry, Graduate School of Science, Chiba University, Chiba, Chiba 263 8522, Japan.
Akio KitaoSchool of Life Science and Technology, Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.ORCID 0000-0002-5221-0806 Shigeki KiyonakaDepartment of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Aichi 464 8603, Japan.ORCID 0000-0002-4100-6738 Tomoaki MatsuuraEarth-Life Science Institute (ELSI), Institute of Science Tokyo, Meguro, Tokyo 152 8550, Japan.ORCID 0000-0003-1015-6781 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Adenosine A2 Receptor AntagonistsDirected Molecular EvolutionReceptor, Adenosine A2ARibosomesTriazinesTriazolesHEK293 CellsHumansMolecular Dynamics SimulationProtein BindingAdenosine A2 Receptor AntagonistsReceptor, Adenosine A2ATriazinesTriazolesZM 241385
Identifiers
PMID41789785
PMCPMC13003494
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390